Insulin × glycemic control

TrialBMJ (Clinical research ed.)2009

Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial.

Søren S Lund et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 459 people · 2009

Not counted

Probably lowered glycemic control

−2.51kg−4.07 to −0.95

As reported

difference −2.51 kg, 95% CI −4.07 to −0.95

One number in the abstract

the abstract, start to end

in mean body weight between treatments -2.51 kg, 95% confidence interval

← favours treatmentfavours comparator →
could be chance
Glycemic control
−2.51−4.07 to −0.95
MetforminSulfonylureas & glinidesInsulinGlycemic control
1 / 3

20 papers cite it

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 19900993